Novellus

概述

国家	United Kingdom
成立时间	2013
总部	Bromley, England
电话号码	+442033974871
网站
LinkedIn	http://www.linkedin.com/company/novellusbridging
Twitter
Facebook
员工数	15
行业	financial services,
简介	Swiftly delivering Bridging Finance solutions in the UK since 2013. Novellus Limited is an experienced private lender located in Bromley, Kent. Our dedicated team have vast experience in lending to the UK and Ireland property market. Novellus Bridging is a trading style of Novellus Limited and the members of our team have been lending in the UK Bridging market for several years. Novellus Bridging is an unregulated lender and we provide loans secured against a wide range of assets including (but not limited to) buy to let and commercial properties, land (with or without planning) and properties requiring refurbishment or change of use.

查看更多信息

技术

CloudFlare Hosting

Hosting

Cloudflare DNS

Domain Name Services

Facebook Comments

Comments

Google Tag Manager

Tag Management

Lucky Orange

Analytics and Tracking

Microsoft Office 365

Other

Mobile Friendly

Other

Outlook

Email Providers

Typekit

Fonts

WordPress.org

CMS

查看所有技术

常见问题

Novellus 在哪里?

Novellus 的总部位于 Bromley, England

Novellus 的电话号码是多少?

Novellus 的电话号码是 +442033974871

Novellus 的官方网站是什么?

Novellus 的公司官方网站是

Novellus 是做什么的?

Novellus 的业务有哪些?

loans,buytolet loan,auction loans,buy land,commercial loan,bridging,lending

Novellus 的年收入是多少?

Novellus 的收入是 0美元

Novellus 有多少员工?

Novellus 有 15 名员工

Novellus 属于哪个行业?

Novellus 从事以下行业: financial services

Novellus 使用什么技术?

Novellus 使用的一些流行技术包括: CloudFlare Hosting,Cloudflare DNS,Facebook Comments,Google Tag Manager,Lucky Orange,Microsoft Office 365,Mobile Friendly,Outlook,Typekit,WordPress.org

如何联系 Novellus?

Novellus 联系信息: 电话号码:+442033974871，网站:，邮箱：ema***@***.com

Novellus 的社交媒体链接是什么?

Novellus 领英：http://www.linkedin.com/company/novellusbridging,fackbook：,twitte:

Novellus 是一家上市公司吗?

不是

Novellus 的最后一轮融资是什么时候?

Novellus在2020-09-01T00:00:00.000+00:00结束了最后一轮融资,金额达57M$。

谁投资 Novellus?

Novellus 有 2 家投资者,包括 Pontifax, OrbiMed Advisors, HBM Healthcare Investments, Wellington Management, Novartis Venture Fund, SR One、Helsinn Investment Fund SA, Bio Capital Impact Fund, Windham Venture Partners。

See More Information